WIRB-Copernicus Group Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • WIRB-Copernicus Group's estimated revenue is currently $45M per year.
  • WIRB-Copernicus Group's estimated revenue per employee is $166667

Employee Data

  • WIRB-Copernicus Group has 270 Employees.
  • WIRB-Copernicus Group grew their employee count by 13% last year.
  • WIRB-Copernicus Group currently has 66 job openings.

Executive Contacts

NameTitle
Manuela ZosulisDirector, Talent Acquisition
Eric DintzisSenior Director of Testing
Craig SowellChief Marketing Officer
Russ TitschBusiness Development Director Market Intelligence and Insights
Kristen MinogueDirector, Learning and Professional Development
Erick GreenDirector, Business Development
Marco CapassoChief Legal Officer
Joseph MummaVice President, Quality Assurance, Technology-CSO
Brooke MillmanVice President, Consulting Solutions, Site Contracts & Payments
Kristi WoodVice President Strategic Initiatives and Continuous Improvement

What Is WIRB-Copernicus Group?

WCG is the world's largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG's solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials. WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life. For more information, please visit www.wcgclinical.com.

keywords:Biotechnology,Healthcare,Pharmaceuticals

270

Number of Employees

$45M

Revenue (est)

66

Current Jobs

13%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
TCP Reliable
$7.8M420%
TCP Reliable
$7.8M420%
Shionogi
$87M4808%
Trio, An FCB He...
$7.8M40-2%
Vertice Pharma
$7M39-7%
Ortho Dermatolo...
$43.2M24212%
PRI Healthcare ...
$11.5M56-5%
TAIHO ONCOLOGY ...
$35.8M1949%
LEO Pharma Inc....
$42.4M2323%
Specialty Rx
$19.9M12317%

WIRB-Copernicus Group News

08/12/2019 - PE-backed WIRB-Copernicus Group hires adviser for ...

PE-backed WIRB-Copernicus Group, which offers compliance- and eClinical-related services to drive efficiency in the clinical trial process, ...

08/27/2019 - WCG Introduces Velos eResearch eXpress™

PRINCETON, N.J., Aug. 27, 2019 /PRNewswire/ -- The WIRB-Copernicus Group®'s (WCG™) Clinical Services Division introduces Velos ...

08/15/2019 - PE HUB Healthcare Wire Highlights, 8.15.19

One of scale to watch is pharma services company WIRB-Copernicus Group. Read my story to learn who WCG's backers, Arsenal Capital and ...

WIRB-Copernicus Group Funding

DateAmountRoundLead InvestorsReference
2017-05-10$3043295Article
2018-07-26$2604337Article

WIRB-Copernicus Group Executive Hires

DateNameTitleReference
2019-01-31Norman GoldfarbChief Collaboration OfficerArticle

WIRB-Copernicus Group Acquisitions

DateCompany NameAmountNotesReference
2016-03-10Clintrax Global, Inc.Article
2017-05-03ThreeWire IncArticle
2017-05-10MedAvante, IncArticle
2017-11-29Vigilare InternationalArticle
2018-03-28ACI ClinicalArticle
2018-07-26KMR Group, Inc.Article
2019-01-31Model Agreements & Guidelines InternationalArticle